Financial News
Latest News about HLN
Recent news which mentions HLN
Haleon Lifts Annual Sales Forecasts, Says Pricing & Efficiencies Offset Inflationary Pressures
August 02, 2023
Tickers
HLN
From Benzinga
Is GSK Stock Worth Buying Right Now?
July 29, 2023
From Motley Fool
From Benzinga
Haleon Contemplates Sale of Non-Core Businesses, Including Nicotinell Brand: A Strategy Shift Towards Core Products
July 05, 2023
From Benzinga
Virgin Galactic shares tumble, while Trupanian and GSK climb and other stocks on the move
June 23, 2023
From MarketWatch
From Benzinga
Datadog, Compass Diversified, Transocean And This Consumer Health Company: CNBC's 'Final Trades'
May 11, 2023
From Benzinga
KVUE Stock: Should You Buy Into the Kenvue IPO?
May 03, 2023
From InvestorPlace
From Benzinga
Johnson & Johnson Unleashes Kenvue: Tylenol to Neutrogena, $40B Revenue Unit Spinoff Preps for IPO Blitz
April 24, 2023
From Benzinga
Dow Tumbles 150 Points; Tesla Shares Drop After Q1 Results
April 20, 2023
From Benzinga
From Benzinga
This nearly 150-year-old fund hasn’t cut its dividend since 1938. Here are the stocks it likes, and four it doesn’t.
February 10, 2023
From MarketWatch
Jaguars 27-Point Comeback Costs Sports Bettor $1.4 Million: Here's How And Why No 'Sure Thing' Bet Is Safe
January 17, 2023
From Benzinga
Haleon & Microsoft Intend To Make Health Products More Accessible Via AI Technology
October 13, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2022
September 28, 2022
From Benzinga
Burberry Finance Chief Joins GSK As First Woman CFO
September 26, 2022
From Benzinga
Haleon Clocks Double Digit Growth In Interim Revenue, Profits; Sticks To Annual Guidance
September 20, 2022
From Benzinga
Haleon Shares Pop After Rejecting Zantac Indemnification Requests From GSK, Pfizer
September 20, 2022
From Benzinga
Earnings Scheduled For September 20, 2022
September 20, 2022
From Benzinga
From MarketWatch
From Benzinga
GSK defends Zantac ahead of trials that have cratered the stock
August 12, 2022
From MarketWatch
Recalled Heartburn Pill Zantac Sets Fire To Glaxo and Sanofi Shares As Billions In Market Value Goes Up In Smoke
August 11, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
August 11, 2022
From Benzinga
GSK, PFE, SNY Stocks Fall on Zantac Litigation
August 11, 2022
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
